These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


222 related items for PubMed ID: 19056158

  • 1. Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo.
    Fraser CK, Blake SJ, Diener KR, Lyons AB, Brown MP, Hughes TP, Hayball JD.
    Exp Hematol; 2009 Feb; 37(2):256-65. PubMed ID: 19056158
    [Abstract] [Full Text] [Related]

  • 2. Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigens.
    Fei F, Yu Y, Schmitt A, Rojewski MT, Chen B, Greiner J, Götz M, Guillaume P, Döhner H, Bunjes D, Schmitt M.
    Exp Hematol; 2008 Oct; 36(10):1297-308. PubMed ID: 18619726
    [Abstract] [Full Text] [Related]

  • 3. Combining dasatinib with dexamethasone long-term leads to maintenance of antiviral and antileukemia specific cytotoxic T cell responses in vitro.
    Nerreter T, Distler E, Köchel C, Einsele H, Herr W, Seggewiss-Bernhardt R.
    Exp Hematol; 2013 Jul; 41(7):604-614.e4. PubMed ID: 23466625
    [Abstract] [Full Text] [Related]

  • 4. The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro.
    Blake S, Hughes TP, Mayrhofer G, Lyons AB.
    Clin Immunol; 2008 Jun; 127(3):330-9. PubMed ID: 18395492
    [Abstract] [Full Text] [Related]

  • 5. Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells.
    Fei F, Yu Y, Schmitt A, Rojewski MT, Chen B, Götz M, Döhner H, Bunjes D, Schmitt M.
    Br J Haematol; 2009 Jan; 144(2):195-205. PubMed ID: 19016717
    [Abstract] [Full Text] [Related]

  • 6. Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells in in vitro study.
    Uchiyama T, Sato N, Narita M, Yamahira A, Iwabuchi M, Furukawa T, Sone H, Takahashi M.
    Hematol Oncol; 2013 Sep; 31(3):156-63. PubMed ID: 23108877
    [Abstract] [Full Text] [Related]

  • 7. Dasatinib inhibits the secretion of TNF-alpha following TLR stimulation in vitro and in vivo.
    Fraser CK, Lousberg EL, Kumar R, Hughes TP, Diener KR, Hayball JD.
    Exp Hematol; 2009 Dec; 37(12):1435-44. PubMed ID: 19786067
    [Abstract] [Full Text] [Related]

  • 8. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
    Rowe HM, Lopes L, Ikeda Y, Bailey R, Barde I, Zenke M, Chain BM, Collins MK.
    Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
    [Abstract] [Full Text] [Related]

  • 9. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M.
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [Abstract] [Full Text] [Related]

  • 10. Different mechanisms regulate CD4(+) T cell independent induction of oral and nasal tolerance of CD8(+) T cells.
    van den Berg H, Greuter M, Kraal G, den Haan JM.
    Immunobiology; 2010 Nov; 215(2):163-71. PubMed ID: 19278748
    [Abstract] [Full Text] [Related]

  • 11. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z, Ahmed KA, Hao S, Zhang X, Xie Y, Munegowda MA, Meng Q, Chibbar R, Xiang J.
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [Abstract] [Full Text] [Related]

  • 12. The opposite effect of tumor-infiltrating natural killer cells on in vivo priming of tumor-specific CD8+ T cells and CD4+ T cells.
    Terao H, Harada M, Kurosawa S, Shinomiya Y, Ito O, Tamada K, Takenoyama M, Nomoto K.
    Immunobiology; 1996 Jul; 195(2):172-86. PubMed ID: 8877394
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.
    Zimmermann M, Flechsig C, La Monica N, Tripodi M, Adler G, Dikopoulos N.
    J Hepatol; 2008 Jan; 48(1):51-60. PubMed ID: 17998148
    [Abstract] [Full Text] [Related]

  • 14. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S, Yuan J, Xiang J.
    J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
    [Abstract] [Full Text] [Related]

  • 15. Cellular mechanisms involved in protection against influenza virus infection in transgenic mice expressing a TCR receptor specific for class II hemagglutinin peptide in CD4+ and CD8+ T cells.
    Bot A, Casares S, Bot S, von Boehmer H, Bona C.
    J Immunol; 1998 May 01; 160(9):4500-7. PubMed ID: 9574556
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib.
    Hassold N, Seystahl K, Kempf K, Urlaub D, Zekl M, Einsele H, Watzl C, Wischhusen J, Seggewiss-Bernhardt R.
    Int J Cancer; 2012 Sep 15; 131(6):E916-27. PubMed ID: 22419518
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of cell growth and up-regulation of MAD2 in human oesophageal squamous cell carcinoma after treatment with the Src/Abl inhibitor dasatinib.
    Wang L, Guo B, Wang R, Jiang Y, Qin S, Liang S, Zhao Y, Guo W, Li K, Fan X.
    Clin Sci (Lond); 2012 Jan 15; 122(1):13-24. PubMed ID: 21751967
    [Abstract] [Full Text] [Related]

  • 18. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
    Wiedig CA, Kramer U, Garbom S, Wolf-Watz H, Autenrieth IB.
    Vaccine; 2005 Oct 10; 23(42):4984-98. PubMed ID: 15985316
    [Abstract] [Full Text] [Related]

  • 19. CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo.
    Serre K, Giraudo L, Siret C, Leserman L, Machy P.
    Eur J Immunol; 2006 Jun 10; 36(6):1386-97. PubMed ID: 16673447
    [Abstract] [Full Text] [Related]

  • 20. Aspergillus fumigatus extract differentially regulates antigen-specific CD4+ and CD8+ T cell responses to promote host immunity.
    Tao J, Segal BH, Eppolito C, Li Q, Dennis CG, Youn R, Shrikant PA.
    J Leukoc Biol; 2006 Sep 10; 80(3):529-37. PubMed ID: 16793916
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.